Facebook Linkedin RSS Twitter Youtube
Home 2023

Hematopoietic stem cell transplantation

Sustained Graft-Versus-Host Disease Depends on Tissue-Resident Seeds
Cancer

Sustained Graft-Versus-Host Disease Depends on Tissue-Resident Seeds

Gut Microbiome Drives Production of Neutrophils after Prolonged Chemotherapy
Drug Discovery

Gut Microbiome Drives Production of Neutrophils after Prolonged Chemotherapy

Blood Precursor Cell Requiring Retinoic Acid Identified
Insights

Blood Precursor Cell Requiring Retinoic Acid Identified

Complementary Challenge: Apellis Throws Down the Gauntlet
Drug Discovery

Complementary Challenge: Apellis Throws Down the Gauntlet

A ‘Human’ Touch vs. COVID-19
Coronavirus

A ‘Human’ Touch vs. COVID-19

Athersys Stem Cell Therapy Targets Top Cause of COVID-19 Deaths
Coronavirus

Athersys Stem Cell Therapy Targets Top Cause of COVID-19 Deaths

Shingles Vaccine Reduced Rash Outbreaks in Stem Cell Transplant Patients
Drug Discovery

Shingles Vaccine Reduced Rash Outbreaks in Stem Cell Transplant Patients

Tips to Design Successful Immuno-Oncology Efficacy Studies to Push Drug Discovery Further
Drug Discovery

Tips to Design Successful Immuno-Oncology Efficacy Studies to Push Drug Discovery Further

Innate Pharma Leukemia Candidate Lirilumab Fails Phase II Trial
Cancer

Innate Pharma Leukemia Candidate Lirilumab Fails Phase II Trial

Daiichi Sankyo to Acquire Ambit Biosciences for Up to $410M
Cancer

Daiichi Sankyo to Acquire Ambit Biosciences for Up to $410M

123Page 2 of 3
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.